Skip to main content

and
  1. Article

    Open Access

    Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues

    Serial multi-omic analysis of proteome, phosphoproteome, and acetylome provides insights into changes in protein expression, cell signaling, cross-talk and epigenetic pathways involved in disease pathology and...

    Jennifer G. Abelin, Erik J. Bergstrom, Keith D. Rivera in Nature Communications (2023)

  2. No Access

    Article

    Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

    Interactions between T cell receptors (TCRs) and their cognate tumour antigens are central to antitumour immune responses13; however, the relationship between phenotypic characteristics and TCR properties is not...

    Giacomo Oliveira, Kari Stromhaug, Susan Klaeger, Tomasz Kula, Dennie T. Frederick in Nature (2021)

  3. Article

    Open Access

    Author Correction: Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics

    Mathias Wilhelm, Daniel P. Zolg, Michael Graber in Nature Communications (2021)

  4. Article

    Open Access

    Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics

    Characterizing the human leukocyte antigen (HLA) bound ligandome by mass spectrometry (MS) holds great promise for develo** vaccines and drugs for immune-oncology. Still, the identification of non-tryptic pe...

    Mathias Wilhelm, Daniel P. Zolg, Michael Graber in Nature Communications (2021)

  5. Article

    Open Access

    Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells

    Pancreatic ductal adenocarcinoma (PDAC) has a collagen-rich dense extracellular matrix (ECM) that promotes malignancy of cancer cells and presents a barrier for drug delivery. Data analysis of our published ma...

    Chenxi Tian, Ying Huang, Karl R. Clauser, Steffen Rickelt in Nature Communications (2021)

  6. Article

    Open Access

    Microscaled proteogenomic methods for precision oncology

    Cancer proteogenomics promises new insights into cancer biology and treatment efficacy by integrating genomics, transcriptomics and protein profiling including modifications by mass spectrometry (MS). A critic...

    Shankha Satpathy, Eric J. Jaehnig, Karsten Krug, Beom-Jun Kim in Nature Communications (2020)

  7. Article

    Open Access

    Site-specific identification and quantitation of endogenous SUMO modifications under native conditions

    Small ubiquitin-like modifier (SUMO) modification regulates numerous cellular processes. Unlike ubiquitin, detection of endogenous SUMOylated proteins is limited by the lack of naturally occurring protease sit...

    Ryan J. Lumpkin, Hongbo Gu, Yiying Zhu, Marilyn Leonard in Nature Communications (2017)

  8. Article

    Open Access

    Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

    Nature Communications 8: Article number: 14864 (2017)); Published: 28 March 2017; Updated: 25 April 2017 The original version of this Article contained a typographical error in the spelling of the author Beifa...

    Kuan-lin Huang, Shunqiang Li, Philipp Mertins, Song Cao in Nature Communications (2017)

  9. Article

    Open Access

    Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

    Recent advances in mass spectrometry (MS) have enabled extensive analysis of cancer proteomes. Here, we employed quantitative proteomics to profile protein expression across 24 breast cancer patient-derived xe...

    Kuan-lin Huang, Shunqiang Li, Philipp Mertins, Song Cao in Nature Communications (2017)

  10. Article

    Open Access

    Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression

    The angiogenic switch, the time at which a tumor becomes vascularized, is a critical step in tumor progression. Indeed, without blood supply, tumors will fail to grow beyond 1 mm3 and are unlikely to disseminate....

    Alexandra Naba, Karl R. Clauser, D. R. Mani, Steven A. Carr in Scientific Reports (2017)

  11. No Access

    Article

    Proteogenomics connects somatic mutations to signalling in breast cancer

    Somatic mutations have been extensively characterized in breast cancer, but the effects of these genetic alterations on the proteomic landscape remain poorly understood. Here we describe quantitative mass-spec...

    Philipp Mertins, D. R. Mani, Kelly V. Ruggles, Michael A. Gillette in Nature (2016)